126 related articles for article (PubMed ID: 33665720)
1. Is the Effect of Tumor Localization on Prognosis Compatible with Real-life Data in Metastatic Colon Cancer? Single-Center Experience: A Retrospective Analysis.
Oytun MG; Bulut G; Gökmen E
J Gastrointest Cancer; 2022 Mar; 53(1):7-15. PubMed ID: 33665720
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and molecular differences in colorectal cancer according to location.
Hsu YL; Lin CC; Jiang JK; Lin HH; Lan YT; Wang HS; Yang SH; Chen WS; Lin TC; Lin JK; Lin PC; Chang SC
Int J Biol Markers; 2019 Mar; 34(1):47-53. PubMed ID: 30854932
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic differences between surgically resected right-sided and left-sided colorectal cancer.
Fukata K; Yuasa N; Takeuchi E; Miyake H; Nagai H; Yoshioka Y; Miyata K
Surg Today; 2020 Mar; 50(3):267-274. PubMed ID: 31612331
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients.
Natsume S; Yamaguchi T; Takao M; Iijima T; Wakaume R; Takahashi K; Matsumoto H; Nakano D; Horiguchi SI; Koizumi K; Miyaki M
Jpn J Clin Oncol; 2018 Jul; 48(7):609-618. PubMed ID: 29767751
[TBL] [Abstract][Full Text] [Related]
5. Differences in oncological outcomes and inflammatory biomarkers between right-sided and left-sided stage I-III colorectal adenocarcinoma.
Guo D; Li X; Xie A; Cao Q; Zhang J; Zhang F; Li W; Chen J
J Clin Lab Anal; 2020 Apr; 34(4):e23132. PubMed ID: 31755593
[TBL] [Abstract][Full Text] [Related]
6. The impact of primary tumor localization on survival and treatment outcomes in patients with metastatic colorectal cancer-a multicenter study.
Sahin S; Karatas F
J BUON; 2019; 24(2):479-487. PubMed ID: 31127994
[TBL] [Abstract][Full Text] [Related]
7. Prognostic importance of tumor location and anti-EGFR therapy in patients with K-RAS wild type metastatic colorectal cancer.
Kucukoner M; Oztekin E; Akdeniz N; Morkuzu S; Yerlikaya H; Urakci Z; Kaplan MA; Isikdogan A
J BUON; 2019; 24(4):1501-1506. PubMed ID: 31646798
[TBL] [Abstract][Full Text] [Related]
8. Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
Huemer F; Thaler J; Piringer G; Hackl H; Pleyer L; Hufnagl C; Weiss L; Greil R
BMC Cancer; 2018 Jan; 18(1):11. PubMed ID: 29298682
[TBL] [Abstract][Full Text] [Related]
9. Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component.
Moretto R; Morano F; Ongaro E; Rossini D; Pietrantonio F; Casagrande M; Antoniotti C; Corallo S; Marmorino F; Cortiula F; Nichetti F; Borelli B; Zucchelli G; Boccaccino A; Masi G; de Braud F; Falcone A; Cremolini C
Clin Colorectal Cancer; 2019 Jun; 18(2):116-124. PubMed ID: 30952563
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials.
Arnold D; Lueza B; Douillard JY; Peeters M; Lenz HJ; Venook A; Heinemann V; Van Cutsem E; Pignon JP; Tabernero J; Cervantes A; Ciardiello F
Ann Oncol; 2017 Aug; 28(8):1713-1729. PubMed ID: 28407110
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of primary tumor localization in patients with metastatic colorectal cancer: Is it beneficial to select targeted treatment? Real-life experience from Turkey.
Cakan B; Acikgoz O; Bilici A; Demir T; Basak Oven B; Hamdard J; Olmuscelik O; Olmez OF; Seker M; Yildiz O
J BUON; 2021; 26(5):1908-1917. PubMed ID: 34761599
[TBL] [Abstract][Full Text] [Related]
12. Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies.
Boeckx N; Koukakis R; Op de Beeck K; Rolfo C; Van Camp G; Siena S; Tabernero J; Douillard JY; André T; Peeters M
Ann Oncol; 2017 Aug; 28(8):1862-1868. PubMed ID: 28449055
[TBL] [Abstract][Full Text] [Related]
13. Improvement in colorectal cancer outcomes over time is limited to patients with left-sided disease.
Rumpold H; Hackl M; Petzer A; Wolf D
J Cancer Res Clin Oncol; 2022 Nov; 148(11):3007-3014. PubMed ID: 34977964
[TBL] [Abstract][Full Text] [Related]
14. Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort study.
Chen KH; Shao YY; Chen HM; Lin YL; Lin ZZ; Lai MS; Cheng AL; Yeh KH
BMC Cancer; 2016 May; 16():327. PubMed ID: 27221731
[TBL] [Abstract][Full Text] [Related]
15. Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer.
Kim D; Kim SY; Lee JS; Hong YS; Kim JE; Kim KP; Kim J; Jang SJ; Yoon YK; Kim TW
BMC Gastroenterol; 2017 Nov; 17(1):121. PubMed ID: 29169325
[TBL] [Abstract][Full Text] [Related]
16. Effect of Tumor Location on Clinicopathological and Molecular Markers in Colorectal Cancer in Eastern China Patients: An Analysis of 2,356 Cases.
Song Y; Wang L; Ran W; Li G; Xiao Y; Wang X; Zhang L; Xing X
Front Genet; 2020; 11():96. PubMed ID: 32161617
[TBL] [Abstract][Full Text] [Related]
17. Analysis of clinicopathological features and prognosis of 1315 cases in colorectal cancer located at different anatomical subsites.
Feng Z; Shi X; Zhang Q; Zhang X; Li X; Chen Z; Liu D; Sun B; Zuo Y; Ren S
Pathol Res Pract; 2019 Oct; 215(10):152560. PubMed ID: 31375274
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Prognostic Value of Primary Tumor Location and KRAS in Metastatic Colorectal Cancer: A Post Hoc Analysis of the OPTIMOX3 DREAM Phase III Study.
Chibaudel B; André T; Tournigand C; Louvet C; Benetkiewicz M; Larsen AK; de Gramont A
Clin Colorectal Cancer; 2020 Sep; 19(3):200-208.e1. PubMed ID: 32303437
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis.
Li Y; Feng Y; Dai W; Li Q; Cai S; Peng J
Clin Colorectal Cancer; 2019 Mar; 18(1):e104-e116. PubMed ID: 30448100
[TBL] [Abstract][Full Text] [Related]
20. The impact of primary tumor location on prognosis after colorectal lung metastasectomy.
Sponholz S; Oguzhan S; Mese M; Schirren M; Kirschbaum A; Schirren J
Int J Colorectal Dis; 2021 Aug; 36(8):1731-1737. PubMed ID: 33712904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
